A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals

Endocrinology

Volumn 140, Issue 3, 1999, Pages 1285-1293

  Alexandre, David ^a   Anouar, Youssef ^a   Jegou, Sylvie ^a   Fournier, Alain ^b   Vaudry, Hubert ^a,c  

^a CNRS   (France)

^b INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE   (Canada)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; ARTICLE; DNA LIBRARY; ENZYME ACTIVATION; FROG; HORMONAL REGULATION; IN SITU HYBRIDIZATION; LIGAND BINDING; MOLECULAR CLONING; MOLECULAR EVOLUTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; RECEPTOR GENE; TISSUE DISTRIBUTION;

EID: 0032936874     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.3.6576     Document Type: Article

References (43)

1. 1. Said SI 1995 Vasoactive intestinal peptide. In: Raebum D, Giembycz MA (eds) Airways Smooth Muscle: Peptide Receptors, Ion Channels and Signals Transduction. Birkhauser Verlag, Basel, pp 87-113
2. 2. Arimura A 1992 Pituitary adenylate cyclase activating polypeptide (PACAP): discovery and current status of research. Regul Pept 37:287-303
3. 3. Miyata A, Arimura A, Dahl RR, Minamino N, Uehara A, Jiang L, Culler MD, Coy DH 1989 Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 164:567-574
4. 4. Miyata A, Jiang L, Dahl RD, Kitada C, Kubo K, Fujino M, Minamino N, Arimura A 1990 Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochem Biophys Res Commun 170:643-648
5. 5. Ogi K, Kimura C, Onda H, Arimura A, Fujino M 1990 Molecular cloning and characterization of cDNA for the precursor of rat pituitary adenylate cyclase activating polypeptide (PACAP). Biochem Biophys Res Commun 173:1271-1279
6. 6. Itoh N, Obata K, Yanaihara N, Okamoto H 1983 Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, PHM-27. Nature 304:547-549
7. 7. Chartrel N, Tonon MC, Vaudry H, Conlon JM 1991 Primary structure of frog pituitary adenylate cyclase-activating polypeptide (PACAP) and effects of ovine PACAP on frog pituitary. Endocrinology 129:3367-3371
8. 8. McRory JE, Parker DB, Ngamvongchon S, Sherwood NM 1995 Sequence and expression of cDNA for pituitary adenylate cyclase activating polypeptide (PACAP) and growth hormone-releasing hormone (GHRH)-like peptide in catfish. Mol Cell Endocrinol 108:169-177
9. 9. McRory JE, Parker RL, Sherwood NM 1997 Expression and alternative processing of a chicken gene encoding both growth hormone-releasing hormone and pituitary adenylate cyclase-activating polypeptide. DNA Cell Biol 16:95-102
10. 10. McRory J, Sherwood NM 1997 Two protochordate genes encode pituitary adenylate cyclase-activating polypeptide and related family members. Endocrinology 138:2380-2390
11. 11. Chartrel N, Wang Y, Fournier A, Vaudry H, Conlon JM 1995 Frog vasoactive intestinal polypeptide and galanin: primary structures and effects on pituitary adenylate cyclase. Endocrinology 136:3079-3086
12. 12. Arimura A, Shioda S 1995 Pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors: neuroendocrine and endocrine interaction. Front Neuroendocrinol 16:53-88
13. 13. Yon L, Chartrel N, Feuilloley M, De Marchis S, Fournier A, De Rijk E, Pelletier G, Roubos E, Vaudry H 1994 Pituitary adenylate cyclase-activating polypeptide stimulates both adrenocortical cells and chromaffin cells in the frog adrenal gland. Endocrinology 135:2749-2758
14. 14. Parker DB, Power ME, Swanson P, Rivier J, Sherwood NM 1997 Exon skipping in the gene encoding pituitary adenylate cyclase-activating polypeptide in salmon alters the expression of two hormones that stimulate growth hormone release. Endocrinology 138:414-423
15. 15. Rawlings SR, Hezareh M 1996 Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP/VIP receptors: actions on the anterior pituitary gland. Endocr Rev 17:4-29
16. 16. Hamar AJ, Arimura A, Gozes I, Journot L, Laburthe M, Pisegna JR, Rawlings SR, Robberecht P, Said SI, Sreedharan SP, Wank SA, Waschek JA 1998 International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol Rev 50:265-270
17. 17. Ishihara T, Shigemoto R, Mori K, Takahashi K, Nagata S 1992 Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron 8:811-819
18. 18. Sreedharan SP, Patel DR, Huang J-X, Goetzl EJ 1993 Cloning and functional expression of a human neuroendocrine vasoactive intestinal peptide receptor. Biochem Biophys Res Commun 193:546-553
19. 2 receptor: molecular characterization of a cDNA encoding a novel receptor for vasoactive intestinal peptide. FEBS Lett 334:3-8
20. 20. Inagaki N, Yoshida H, Mizuta M, Mizuno N, Fujii Y, Gonoi T, Miyazaki J-I, Seino S 1994 Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells. Proc Natl Acad Sci USA 91:2679-2683
21. 21. Spengler D, Waeber C, Pantaloni C, Holsboer F, Bockaert J, Seeburg PH, Journot L 1993 Differential signal transduction by five splice variants of the PACAP receptor. Nature 365:170-175
22. 22. Pisegna JR, Wank SA 1993 Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor. Proc Natl Acad Sci USA 90:6345-6349
23. 23. Usdin TB, Bonner TI, Mezey E 1994 Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions. Endocrinology 135:2662-2680
24. 24. Wei Y, Mojsov S 1996 Tissue specific expression of different human receptor types for pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide: implication for their role in human physiology. J Neuroendocrinol 8:811-817
25. receptor messenger RNA in the rat brain and pituitary gland as assessed by in situ hybridization. Neuroscience 67:409-418
26. 26. Vilardaga J-P, De Neef P, Di Paolo E, Bollen A, Waelbroeck M, Robberecht P 1995 Properties of chimeric secretin and VIP receptor proteins indicate the importance of the N-terminal domain for ligand discrimination. Biochem Biophys Res Commun 211:885-891
27. 27. Couvineau A, Gaudin P, Maoret J-J, Rouyer-Fessard C, Nicole P, Laburthe M 1995 Highly conserved aspartate 68, tryptophane 73 and glycine 109 in the N-terminal extracellular domain of the human VIP receptor are essential for its ability to bind VIP. Biochem Biophys Res Commun 206:246-252
28. 28. Hashimoto H, Ogawa N, Hagihara N, Yamamoto K, Imanishi K, Nogi H, Nishino A, Fujita T, Matsuda T, Nagata S, Baba A 1997 Vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide receptor chimeras reveal domains that determine specificity of vasoactive intestinal polypeptide binding and activation. Mol Pharmacol 52:128-135
29. 29. Du K, Nicole P, Couvineau A, Laburthe M 1997 Aspartate 196 in the first extracellular loop of the human VIP1 receptor is essential for VIP binding and VIP-stimulated cAMP production. Biochem Biophys Res Commun 230:289-292
30. 30. Nicole P, Du K, Couvineau A, Laburthe M 1998 Site-directed mutagenesis of human vasoactive intestinal peptide receptor subtypes VIP1 and VIP2: evidence for difference in the structure-function relationship. J Pharmacol Exp Ther 284:744-750
31. 31. Anouar Y, Jégou S, Alexandre D, Lihrmann I, Conlon JM, Vaudry H 1996 Molecular cloning of frog secretogranin II reveals the occurrence of several highly conserved potential regulatory peptides. FEBS Lett 394:295-299
32. 32. Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
33. 33. Tostivint H, Lihrmann I, Bucharles C, Vieau D, Coulouarn Y, Fournier A, Conlon JM, Vaudry H 1996 Occurrence of two somatostatin variants in the frog brain: characterization of the cDNAs, distribution of the mRNAs, and receptor-binding affinities of the peptides. Proc Natl Acad Sci USA 93:12605-12610
34. 34. Von Heijne G 1986 A new method for predicting signal sequence cleavage sites. Nucleic Acids Res 14:4683-4690
35. 35. Gaudin P, Couvineau A, Maoret J-J, Rouyer-Fessard C, Laburthe M 1995 Mutational analysis of cysteine residues within the extracellular domains of the human vasoactive intestinal peptide (VIP) 1 receptor identifies seven mutants that are defective in VIP binding. Biochem Biophys Res Commun 211:901-908
36. 36. Knudsen SM, Tams JW, Wulff BS, Fahrenkrug J 1997 A disulfide bond between conserved cysteines in the extracellular loops of the human VIP receptor is required for binding and activation. FEBS Lett 412:141-143
37. 37. Couvineau A, Fabre C, Gaudin P, Maoret J-J, Laburthe M 1996 Mutagenesis of N-glycosylation sites in the human vasoactive intestinal peptide 1 receptor. Evidence that asparagine 58 or 69 is crucial for correct delivery of the receptor to plasma membrane. Biochemistry 35:1745-1752
38. 1 receptor. Three nonadjacent amino acids are responsible for species selectivity with respect to recognition of peptide histidine isoleucineamide. J Biol Chem 271:12795-12800
39. 39. Butler AB, Hodos W 1996 Dorsal pallium. In: Butler AB, Hodos W (eds) Comparative Vertebrate Neuroanatomy-Evolution and Adaptation. Wiley, Liss, New York, pp 370-379
40. 40. Rawlings SR, Piuz I, Schlegel W, Bockaert J, Journot L 1995 Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs. Endocrinology 136:2088-2098
41. 41. Chow BK-C, Yuen TT-H, Chan K-W 1997 Molecular evolution of vertebrate VIP receptors and functional characterization of a VIP receptor from goldfish Carassius auratus. Gen Comp Endocrinol 105:176-185
42. 42. Lok S, Kuijper JL, Jelinek LJ, Kramer JM, Whitmore TE, Sprecher CA, Mathewes S, Grant FJ, Biggs SH, Rosenberg GB, Sheppard PO, O'Hara PJ, Foster DC, Kindsvogel W 1994 The human glucagon receptor encoding gene: structure, cDNA sequence and chromosomal localization. Gene 140:203-209
43. 43. Chow BK-C 1995 Molecular cloning and functional characterization of a human secretin receptor. Biochem Biophys Res Commun 212:204-211